Trials / Completed
CompletedNCT04907149
Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970
A Phase 1, Open-label Study to Investigate the Pharmacokinetics and Metabolism of GLPG3970 in Healthy Male Subjects Following a Single Oral Dose of GLPG3970 Relative to an Intravenous [14C]GLPG3970 Microtracer and Single Oral [14C]GLPG3970 Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Galapagos NV · Industry
- Sex
- Male
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A study in healthy male volunteers to assess how the radiolabelled test medicine is taken up and broken down by the body when given by short infusion into a vein and when given by the mouth in the form of a tablet and an oral solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLPG3970 film-coated tablet | Participants will receive a single oral dose of GLPG3970. |
| DRUG | [14C]GLPG3970 solution for infusion | Participants will receive an i.v. microtracer microdose. |
| DRUG | [14]GLPG3970 oral solution | Participants will receive a single oral dose \[14C\]GLPG3970. |
Timeline
- Start date
- 2021-06-07
- Primary completion
- 2021-07-12
- Completion
- 2021-07-12
- First posted
- 2021-05-28
- Last updated
- 2021-07-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04907149. Inclusion in this directory is not an endorsement.